These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 24890096)
1. Novel pharmacological approaches for the treatment of acne vulgaris. Valente Duarte de Sousa IC Expert Opin Investig Drugs; 2014 Oct; 23(10):1389-410. PubMed ID: 24890096 [TBL] [Abstract][Full Text] [Related]
2. New and emerging drugs for the treatment of acne vulgaris in adolescents. Valente Duarte De Sousa IC Expert Opin Pharmacother; 2019 Jun; 20(8):1009-1024. PubMed ID: 30848961 [TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for the treatment of acne. Aslam I; Fleischer A; Feldman S Expert Opin Emerg Drugs; 2015 Mar; 20(1):91-101. PubMed ID: 25474485 [TBL] [Abstract][Full Text] [Related]
4. Newer approaches in topical combination therapy for acne. Fu LW; Vender RB Skin Therapy Lett; 2011 Oct; 16(9):3-6. PubMed ID: 22089505 [TBL] [Abstract][Full Text] [Related]
6. Overview of acne and its treatment. Thiboutot DM Cutis; 2008 Jan; 81(1 Suppl):3-7. PubMed ID: 18338651 [TBL] [Abstract][Full Text] [Related]
7. Do we really need topical antibiotics in our new treatment paradigm of acne vulgaris? A novel question to consider based on an updated model of pathogenesis. Kircik LH J Drugs Dermatol; 2013 Aug; 12(8 Suppl):s107. PubMed ID: 23986174 [No Abstract] [Full Text] [Related]
8. Recent advances in acne pathogenesis: implications for therapy. Das S; Reynolds RV Am J Clin Dermatol; 2014 Dec; 15(6):479-88. PubMed ID: 25388823 [TBL] [Abstract][Full Text] [Related]
9. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Sagransky M; Yentzer BA; Feldman SR Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357 [TBL] [Abstract][Full Text] [Related]
10. From pathogenesis of acne vulgaris to anti-acne agents. Cong TX; Hao D; Wen X; Li XH; He G; Jiang X Arch Dermatol Res; 2019 Jul; 311(5):337-349. PubMed ID: 30859308 [TBL] [Abstract][Full Text] [Related]
13. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123 [TBL] [Abstract][Full Text] [Related]
14. Optimizing topical combination therapy for the treatment of acne vulgaris. Zeichner JA J Drugs Dermatol; 2012 Mar; 11(3):313-7. PubMed ID: 22395581 [TBL] [Abstract][Full Text] [Related]
15. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348 [TBL] [Abstract][Full Text] [Related]
16. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? Kinney MA; Yentzer BA; Fleischer AB; Feldman SR J Drugs Dermatol; 2010 May; 9(5):519-24. PubMed ID: 20480795 [TBL] [Abstract][Full Text] [Related]
17. [Acne: pathogenesis and therapy]. Blanken R; van Voorst Vader PC Ned Tijdschr Geneeskd; 1983 Jul; 127(29):1297-303. PubMed ID: 6225028 [No Abstract] [Full Text] [Related]
18. Pathogenesis of acne vulgaris: recent advances. Bhambri S; Del Rosso JQ; Bhambri A J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637 [TBL] [Abstract][Full Text] [Related]
19. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Leyden JJ; Del Rosso JQ; Webster GF Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854 [TBL] [Abstract][Full Text] [Related]